Expansion Opportunity Rutgers Cancer Institute recently opened a new location in Livingston, NJ, in collaboration with RWJBarnabas Health. This geographic expansion provides cross-sell potential for hospital-adjacent services, research collaborations, and radiology or oncology support services across multiple campuses.

Advanced Research As an NCI-designated Comprehensive Cancer Center actively publishing and collaborating (including immunotherapy and MRD testing partnerships), there are frequent opportunities to offer enabling technologies, data analytics, imaging, and clinical trial support to accelerate translational research and patient access.

Technology Stack Adoption of enterprise tools like Salesforce, SAP Concur, Oracle PeopleSoft, and analytics platforms (MATLAB, SAS, Hyperion) indicates openness to integrated vendorsolutions, which creates pathways for procurement of data integration, workflow automation, ERP optimization, and cloud-based research IT services.

Strategic Partnerships Active collaborations with external entities (Haystack Oncology, Contessa, RWJBarnabas Health, ASCO participation) suggest a receptiveness to joint ventures, trial co-development, diagnostic partnerships, and contract research or service agreements that can be scaled regionally.

Funding & Scale With substantial revenue range and targeted research funding, there is appetite for sponsored programs, grant-aligned solutions, and cost-effective platform services that support cancer research infrastructure, clinical operations, and outcomes-focused technologies.